Labcorp on Tuesday raised its annual profit forecast and beat estimates in the third quarter as the laboratory operator ...

Labcorp forecast lower annual revenue growth for its contract research unit on Tuesday, as a prolonged funding crunch ...

Labcorp delivered mixed third-quarter results, with higher sales and raised profit | Labcorp reported solid third-quarter ...

Labcorp posts Q3 EPS of $4.18 and sales of $3.56 billion, exceeding estimates, while revising 2025 guidance amid strong ...

Labcorp boosted its 2025 adjusted per-share earnings target to a range between $16.15 and $16.50 a share from a prior projection of $16.05 to $16.50. The diagnostic testing company cut its revenue ...

Healthcare diagnostics company Labcorp Holdings (NYSE:LH) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 8.6% year on year to $3.56 billion. Its non-GAAP profit of $4.18 per share ...

Labcorp Holdings Inc. ( NYSE:LH ) will pay a dividend of $0.72 on the 11th of December. This payment means the ...

Welcome to the Q3 2025 Labcorp Holdings Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to ...

AI-driven diagnostic efficiency streamlines lab test selection, reducing clinician workload and enhancing patient care at health systems.

Labcorp, one of the country’s largest providers of diagnostic medical testing services, announced today that it will offer ...

Labcorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes ...

The medical laboratory operator posted revenue of $3.56 billion in the period, which matched Street forecasts. Labcorp expects full-year earnings in the range of $16.15 to $16.50 per share.